BPC-157 has shown benefits in animal models of inflammatory bowel disease, NSAID-induced gut damage, and stress ulcers (5)
Thigh circumference decreases, reducing chafing and improving comfort
Across roughly six placebo-controlled trials totaling about 900 obese adults, oral AOD-9604 was as safe and well-tolerated as placebo and the pivotal Phase IIb obesity trial showed no statistically significant weight loss versus placebo [5]
Because of this low oral bioavailability, clinical formulations of ALCAR must be dosed high enough to ensure that an adequate amount of the active compound survives the digestive process and reaches the blood-brain barrier
Diabetes: 3 Devices such as continuous glucose monitors have built market share nonetheless, 4 and are increasingly used by individuals with prediabetes
GLP-1, personalized to you